DiaSys Corporation Share Price

Stocks

DYXC

US2528381070

Advanced Medical Equipment & Technology

OTC Markets Traded
Market Closed - OTC Markets 07:14:37 08/07/2025 pm IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44T 45.05T 41.5T 38.52T 73.15T 49.07L 74.13T 5L 2L 24.09L 2L 2L 83.51L P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 6L 6L 5L 5L 9L 6.16Cr 9L 62.36L 24.27L 3.02Cr 24.25L 23.72L 10Cr EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
-1.12%+2.21%+20.56%+0.05% 19TCr
+1.60%+6.62%-20.50%+31.10% 15TCr
-2.18%+0.44%-4.71%-17.40% 14TCr
-1.20%+2.58%-57.25%-15.66% 6.63TCr
+0.86%+4.39%+23.95%+5.22% 5.48TCr
+1.16%+3.16%-24.29%-28.84% 4.44TCr
-0.11%+2.72%+8.19%+42.98% 3.72TCr
-0.07%-1.68%+7.60%+10.28% 3.69TCr
+4.18%+10.06%-15.01%+1.58% 3.15TCr
Average +0.57%+2.71%-6.83%+3.26% 7.54TCr
Weighted average by Cap. -0.01%+3.29%-4.36%+3.17%

Financials

2006 2007
Net sales 16.88L 14.78L 13.62L 12.64L 24L 16Cr 24.33L 1.63Cr 63.44L 7.9Cr 63.39L 62L 27Cr 16.78L 14.7L 13.54L 12.57L 23.86L 16Cr 24.18L 1.62Cr 63.06L 7.86Cr 63.02L 61.64L 27Cr
Net income -10.48L -9L -8L -8L -14.9L -9.99Cr -15.1L -1.01Cr -39.38L -4.91Cr -39.35L -38.49L -17Cr -8L -7L -6L -6L -11.17L -7.49Cr -11.32L -75.82L -29.51L -3.68Cr -29.49L -28.84L -13Cr
Net Debt 3L 3L 2L 2L 4L 2.88Cr 4L 29.16L 11.35L 1.41Cr 11.34L 11.09L 4.9Cr 6L 5L 5L 4L 8L 5.67Cr 9L 57.4L 22.34L 2.78Cr 22.32L 21.83L 9.65Cr
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock